The global parenteral nutrition market is projected to experience significant growth from 2025 to 2032, with a Compound Annual Growth Rate (CAGR) of 6.2%. This upward trajectory is driven by factors such as the increasing prevalence of chronic diseases, rising malnutrition rates, and advancements in healthcare infrastructure. The market is anticipated to expand from USD 7.22 billion in 2024 to approximately USD 13.17 billion by 2034.
Get a Sample PDF copy of Parenteral Nutrition Market @ https://www.reportsinsights.com/sample/664359
Parenteral nutrition (PN) involves the intravenous administration of essential nutrients, including carbohydrates, proteins, fats, vitamins, and minerals, to patients who cannot obtain adequate nutrition through oral or enteral routes. This method is crucial for individuals with conditions such as gastrointestinal disorders, certain cancers, and severe malnutrition.
Key Market Drivers
Rising Prevalence of Chronic Diseases: The increasing incidence of conditions like cancer, Crohn's disease, and short bowel syndrome necessitates the use of PN to ensure patients receive essential nutrients.
Growing Geriatric Population: The aging global population is more susceptible to diseases that impair nutrient absorption, thereby increasing the demand for PN.
Advancements in PN Formulations: Innovations such as multi-chamber bags and lipid emulsions have improved the safety, efficacy, and convenience of PN therapy.
By Nutrient Type:
Single-Dose Amino Acid Solutions: Held the largest market share in 2023, accounting for 30.7%, due to their compatibility across age groups and reduced adverse effects.
Parenteral Lipid Emulsions: Expected to witness significant growth owing to their role in providing essential fatty acids and energy.
By Stage Type:
Adult: Dominated the market with an 87.1% share in 2023, attributed to the higher prevalence of chronic diseases in adults.
Pediatric: Anticipated to grow steadily, driven by the need for specialized nutrition in preterm infants and children with specific medical conditions.
By Indication:
Nutrition Deficiency: A significant segment due to rising malnutrition cases globally.
Cancer Care: Increasing cancer prevalence necessitates PN to support patients undergoing treatment.
Access full Report Description, TOC, Table of Figure, Chart, etc. @ https://www.reportsinsights.com/industry-forecast/parenteral-nutrition-market-statistical-analysis-664359
North America: Held the largest market share of 41.5% in 2023, driven by advanced healthcare infrastructure and high disease prevalence.
Asia-Pacific: Projected to experience the fastest growth, supported by improving healthcare facilities, rising healthcare expenditure, and increasing awareness about PN.
Key players in the market include Baxter, Fresenius Kabi AG, B. Braun Melsungen AG, and Pfizer Inc. (Hospira Inc.). These companies are focusing on product innovation, strategic partnerships, and regional expansions to strengthen their market position.
Challenges
Despite positive growth prospects, the market faces challenges such as the risk of infections associated with PN administration, high costs of therapy, and a preference for enteral nutrition when feasible. Addressing these issues through improved product designs and cost-effective solutions will be crucial for sustained market growth.